Guangzhou Jet Bio-Filtration Co., Ltd.
SSE:688026.SS
16.08 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 558.658 | 463.098 | 609.824 | 855.658 | 503.934 | 247.496 | 207.48 | 167.043 | 124.023 | 102.788 | 88.265 | 70.023 |
| Cost of Revenue
| 327.302 | 321.287 | 415.643 | 497.019 | 270.535 | 136.857 | 115.794 | 91.103 | 70.2 | 60.723 | 55.986 | 37.543 |
| Gross Profit
| 231.355 | 141.81 | 194.182 | 358.639 | 233.399 | 110.639 | 91.685 | 75.94 | 53.822 | 42.065 | 32.279 | 32.48 |
| Gross Profit Ratio
| 0.414 | 0.306 | 0.318 | 0.419 | 0.463 | 0.447 | 0.442 | 0.455 | 0.434 | 0.409 | 0.366 | 0.464 |
| Reseach & Development Expenses
| 26.25 | 28.507 | 37.337 | 43.84 | 23.897 | 12.563 | 8.64 | 7.87 | 7.623 | 0 | 0 | 6.099 |
| General & Administrative Expenses
| 12.364 | 8.942 | 10.494 | 11.977 | 5.493 | 7.776 | 8.379 | 8.9 | 6.965 | 15.48 | 14.738 | 10.974 |
| Selling & Marketing Expenses
| 9.195 | 11.648 | 25.164 | 24.375 | 22.217 | 17.859 | 15.401 | 13.332 | 12.233 | 8.727 | 8.054 | 6.525 |
| SG&A
| 21.559 | 19.194 | 35.658 | 36.352 | 27.71 | 25.635 | 23.781 | 22.232 | 19.198 | 24.207 | 22.792 | 17.499 |
| Other Expenses
| 87.811 | 54.666 | 16.519 | 15.356 | 0.803 | -2.375 | 0.109 | 3.455 | 5.859 | 3.568 | 4.071 | 2.66 |
| Operating Expenses
| 135.62 | 102.367 | 89.513 | 95.548 | 52.41 | 35.823 | 29.691 | 28.256 | 28.684 | 25.21 | 23.399 | 18.062 |
| Operating Income
| 95.735 | 39.443 | 96.089 | 210.914 | 148.174 | 76.443 | 61.174 | 43.48 | 24.48 | 13.053 | 5.695 | 12.793 |
| Operating Income Ratio
| 0.171 | 0.085 | 0.158 | 0.246 | 0.294 | 0.309 | 0.295 | 0.26 | 0.197 | 0.127 | 0.065 | 0.183 |
| Total Other Income Expenses Net
| -0.118 | -1.123 | 1.915 | -15.268 | -0.412 | -0.059 | 0.109 | 3.455 | 5.859 | 3.568 | 4.071 | 2.66 |
| Income Before Tax
| 95.617 | 38.32 | 98.005 | 195.646 | 147.762 | 76.384 | 61.283 | 46.935 | 30.339 | 16.621 | 9.766 | 15.453 |
| Income Before Tax Ratio
| 0.171 | 0.083 | 0.161 | 0.229 | 0.293 | 0.309 | 0.295 | 0.281 | 0.245 | 0.162 | 0.111 | 0.221 |
| Income Tax Expense
| 22.655 | 3.221 | 10.311 | 24.488 | 28.39 | 10.231 | 8.496 | 6.81 | 4.501 | 3.187 | 1.616 | 1.897 |
| Net Income
| 72.19 | 34.788 | 87.712 | 171.158 | 119.371 | 66.153 | 52.835 | 40.356 | 26.072 | 13.434 | 8.149 | 13.556 |
| Net Income Ratio
| 0.129 | 0.075 | 0.144 | 0.2 | 0.237 | 0.267 | 0.255 | 0.242 | 0.21 | 0.131 | 0.092 | 0.194 |
| EPS
| 0.52 | 0.25 | 0.62 | 1.22 | 0.85 | 0.47 | 0.54 | 0.41 | 0.26 | 0.23 | 0.14 | 0.33 |
| EPS Diluted
| 0.52 | 0.25 | 0.62 | 1.22 | 0.85 | 0.47 | 0.54 | 0.41 | 0.26 | 0.23 | 0.14 | 0.33 |
| EBITDA
| 178.283 | 123.668 | 174.274 | 248.792 | 171.348 | 88.381 | 71.715 | 49.567 | 34.036 | 24.55 | 13.936 | 17.459 |
| EBITDA Ratio
| 0.319 | 0.267 | 0.286 | 0.291 | 0.34 | 0.357 | 0.346 | 0.297 | 0.274 | 0.239 | 0.158 | 0.249 |